Dr Emma Woodward studied medicine at the University of Cambridge where she also completed a PhD studying familial phaeochromocytoma and familial renal cancer. Dr Woodward then undertook training in adult medicine in London, Lausanne and Northern Ireland prior to her higher specialist training in Clinical Genetics in Birmingham. During this time she received an NIHR Clinician Scientist Award and undertook further study of familial renal cancer. She became a consultant at Birmingham Women's Hospital in 2008 and at St Mary’s Hospital in 2015.
Dr Woodward's current research is aimed at understanding the inherited predisposition to cancer, in particular thyroid cancer and also whether structural genomic variants influence cancer predisposition risk. Her clinical specialist interest is in the inherited predisposition to endocrine tumours and renal cancer.